Prostate Disorders Clinical Trials

A listing of Prostate Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1257 clinical trials
Featured trial
Do you have any of these symptoms when you urinate?

Do you have any of these symptoms when you urinate?

  • 172 views
  • 08 Nov, 2020
  • 1 location
PSMA-PET Registry for Recurrent Prostate Cancer (PREP)

our ability to characterize patterns of recurrence and personalize therapies in men with recurrent prostate cancer after primary treatment.

bone scan
ct scan
karnofsky performance status
positron emission tomography
prostatectomy
  • 108 views
  • 15 Feb, 2022
  • 6 locations
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

This randomized phase II trial studies how well surgical removal of the prostate and antiandrogen therapy with or without docetaxel work in treating men with newly diagnosed prostate cancer that

  • 44 views
  • 16 Mar, 2022
  • 13 locations
A Study of Tarlatamab (AMG 757) in Participants With Neuroendocrine Prostate Cancer

To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).

  • 1 views
  • 12 May, 2022
  • 19 locations
Cotrimoxazole Prophylaxis in Transurethral Resection or Greenlight Laser Vaporisation of the Prostate (CITrUS)

The optimal duration of antimicrobial prophylaxis (study medication Cotrimoxazole (Trimethoprim/Sulfamethoxazole)) in transurethral resection of the prostate and Greenlight Laser vaporisation of

  • 51 views
  • 14 May, 2022
  • 4 locations
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

The purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in patients with metastatic castrate resistant prostate cancer (mCRPC). There will

bone lesions
soft tissue disease
enzalutamide
prostate adenocarcinoma
receptor activator of nuclear factor kappa-b ligand
  • 3 views
  • 06 Jun, 2022
  • 31 locations
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as first-line treatment by assessment of radiographic progression-free survival (rPFS) in mCRPC subjects unselected for deoxyribonucleic acid (DNA) damage repair deficiencies (DRD) status (Cohort 1) to evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as …

  • 5 views
  • 29 May, 2022
  • 112 locations
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)

The purpose of this study is to evaluate the efficacy and safety of [Lu-177]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with

  • 0 views
  • 16 Jun, 2022
  • 38 locations
  • 17 views
  • 13 Jul, 2022
  • 85 locations